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tematic study of the cellular RNA component transcribed
by RNA polymerase II, to facilitate research on cellular
heterogeneity, disease-specific biomarkers, and networks
of expression was recently highlighted in the Journal of
Translational Medicine by Zhu et al. [1]. We read this edi-
torial with great interest and believe it has important im-
plications for future research into cardiovascular diseases.
As discussed by Zhu and colleagues, gene expres-
sion reflects carefully regulated interactions between
genomic DNA, epigenetic modifications, and RNA
post-transcriptional modifications. Careful study of the
“trancriptome” has led to fundamental discoveries in cha-
racterizing temporal and spatial patterns of gene expres-
sion. Recent advances in both array- and sequence-based
technologies are likely to accelerate application to car-
diovascular research. For example, gene-expression pro-
filing of peripheral-blood specimens has been studied as a
means of avoiding invasive endomyocardial biopsy in sur-
veillance for rejection after cardiac transplantation or car-
diac catheterization in diagnosing obstructive coronary
artery disease [2,3].
However, these initial forays have involved samples of
thousands of cells with expression output reflecting an
average across this population. Recent advances in tech-
nology and bioinformatics have enabled documentation of
substantial heterogeneity across seemingly similar cells
and enabled high-resolution transcriptomics of single-cells
[4]. Although techniques are rapidly evolving to overcome
existing limitations, single-cell transcriptomics studies
generally involve: 1) Isolation of individual cells and subse-
quent lysis; 2) Reverse transcription of RNA into cDNA;* Correspondence: nehal.mehta@nih.gov
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arrays or deep sequencing; 5) Bioinformatics processing to
allow for quantification and comparison to reference
libraries [5]. Ongoing research will facilitate improved
cellular isolation, more comprehensive capture of both
coding and noncoding RNAs, and distinguishing random
or stochastic variation from true signals.
Single-cell genome and transcriptome analysis has clear
utility for circumstances in which the cell population of
interest is rare. For example, genetic testing of preimplan-
tation embryos has become a routine aspect of in vitro
fertilization for couples at increased risk of passing on her-
itable disorders [6]. Traditional techniques have involved
biopsy of one or two cells from a preimplantation embryo
and subjecting them to locus- and often family-specific
analysis using either PCR or fluorescent in situ hybri-
dization assays. However, ongoing work has sought to
generalize this process using array-based single nucleotide
polymorphism assessment, comparative genomic hybridi-
zation that allows for chromosomal aberration assessment
and next-generation sequencing that allows for detection
of de novo mutations in an unbiased fashion [7]. Tran-
scriptome profiling would allow for systematic assessment
of the perturbations-induced by these abnormalities and
further assist in preimplantation counseling and selection.
Similarly, tumor cells circulating in peripheral blood can
be isolated for noninvasive studies of human malignancy
[8]. For example, microfluidic-based isolation and ex-
pression profiling of individual breast cancer cells from
humans demonstrated marked variability in expression of
cancer-related genes that would have been obscured if a
larger population of cells was analyzed simultaneously [9].
Moving forward, researchers will increasingly be able to
utilize single-cell expression profiling tools in the study of
cardiovascular disease. For example, intravenous injection
of low-dose LPS to induce experimental endotoxemia is antral Ltd. This is an Open Access article distributed under the terms of the
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types including adipose inflammation and insulin resis-
tance [10]. RT-PCR assessments in adipose biopsies
note dramatic increases in mRNA levels of the inflam-
matory cytokines interleukin-6 and TNF-alpha, among
others. However, single-cell RNA sequencing of bone-
marrow-derived dendritic cells after exposure to LPS
noted a bimodal distribution of both expression pat-
terns and RNA splicing across populations of seemingly
similar cells [11]. The increased resolution of these ana-
lyses may improve future LPS-challenge experiments by
allowing for the identification of relevant subtypes of
cells, increase understanding of cellular interactions,
and provide the foundation for regulatory network
assembly.
Exponential decreases in the cost of sequencing have led
to an explosion discovery of genetic links to cardio-
vascular disease over the last 10 years, driven largely by
genome-wide association studies (GWAS) that allows for
efficient phenotyping and unbiased analysis for association
with a trait of interest. However, deciphering the causal
and mechanistic pathways underlying these associations
has proven challenging. For example, a 2012 review out-
lined 33 loci associated with myocardial infarction or
coronary artery disease, of which the mechanism was un-
known for 22 [12]. Alterations in gene expression are
likely to play a key role in a number of these associations.
For example, a common polymorphism at the 1p13 locus
linked to both LDL-cholesterol and myocardial infarction
creates a transcription factor binding site that modulates
hepatocyte SORT1 expression [13]. The 9p21 locus linked
to atherosclerosis and myocardial infarction is thought to
mediate its effect by inducing expression of ANRIL, a non-
coding RNA, involved in regulation of the cell cycle [14].
Despite some success stories, it has become clear
that thoughtful investigation of genotype-phenotype cor-
relations will be needed to further understand complex
cardiovascular diseases. Some of these will occur at the or-
ganismal or tissue level. For example, carriers of the R19X
variant at the APOC3 gene, involved in breakdown of cir-
culating fats have substantially decreased postprandial
serum triglycerides when assessed after an experimental
high-fat challenge [15]. However, integration of genetic,
epigenetic, transcriptomic, and proteomic technologies in
data from single cells in tissues of interest are likely to
emerge as powerful tools in the future. Quantifying allele-
specific expression within a single cell is likely to provide
important insights into gene regulation [16]. If tissue from
a genotype of interest is unavailable, genome editing of
pluripotent stem cells are likely to serve as viable surro-
gates [17]. These single-cell platforms can then serve as
valuable reagents in studying the impact of pharmaco-
logic, molecular, or environmental perturbations on the
transcriptome.We look forward to the coming era of “team science”
in which investigators from the previously diverse fields
of epidemiology, physiology, genomics, transcriptomics,
and pharmacology come together in the development of
novel biomarkers and pharmacologic therapies in the
treatment of cardiovascular disease.
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